MOCHIDA PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 4534 for the last quarter is 28.74 B JPY, and it's 16.23% higher compared to the previous quarter. The net income of Q3 23 is 1.61 B JPY.